α-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products

Clinical Science

Volumn 96, Issue 1, 1999, Pages 75-82

  Kunt, Thomas ^a   Forst, Thomas ^a   Wilhelm, Axel ^a   Tritschler, Hans ^a,b   Pfuetzner, Andreas ^a   Harzer, Oliver ^a   Engelbach, Martin ^a   Zschaebitz, Albrecht ^a   Stofft, Eckart ^a   Beyer, Juergen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ASTA MEDICA AG   (Germany)

Author keywords

lipoic acid; Advanced glycation end products; Vascular cell adhesion molecule 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; THIOCTIC ACID; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIOXIDANTS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; THIOCTIC ACID; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032902482     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19980224     Document Type: Article

References (48)

1. 1 Brownlee, M., Cerami, A. and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321
2. 2 Brownlee, M. (1994) Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 43, 836-841
3. 3 Berg, T. J., Bangstad, H. J., Torjesen, P. A., Osterby, R., Bucala, R. and Hanssen, K. F. (1997) Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Metabolism 46, 661-665
4. 4 Beisswenger, P. J., Makita, Z., Curphey, T. J. et al. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44, 824-829
5. 5 Korbet, S. M., Makita, Z., Firanek, C. A. and Vlassara, H. (1993) Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. Am. J. Kidney Dis. 22, 588-591
6. 6 Schmidt, A. M., Hori, O., Chen, J. X. et al. (1995) Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated Vasculopathy of diabetes. J. Clin. Invest. 96, 1395-1403
7. 7 Ritthaler, U., Deng, Y., Zhang, Y. et al. (1995) Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am. J. Pathol. 146, 688-694
8. 8 Schmidt, A. M., Mora, R., Cao, R. et al. (1994) The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J. Biol. Chem. 269, 9882-9888
9. 9 Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., Archer, D. B. and Vlassara, H. (1997) Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. J. Pathol. 150, 523-531
10. 10 Yang, Z., Makita, Z., Horii, Y. et al. (1991) Two novel rat liver membrane proteins that bind advanced glycosylation end products: relationship to macrophage receptor for glucose-modified proteins. J. Exp. Med. 174, 515-524
11. 11 Li, J. and Schmidt, A. M. (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem, 272, 16498-16506
12. 12 Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L. and Stern, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14, 1521-1528
13. 13 Bierhaus, A., Chevion, S., Chevion, M. et al. (1997) Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 46, 1482-1490
14. 14 Godin, T. V., Wohaieb, S. A., Garnett, M. E. and Goumeniouk, A. D. (1988) Antioxidant enzyme alterations in experimental and clinical diabetes. Mol. Cell. Biochem. 84, 223-231
15. 15 Packer, L., Witt, E. H. and Tritschler, H. J. (1995) Alpha-lipoic acid as a biological antioxidant. Free Rad. Biol. Med. 19, 227-250
16. 16 Nagamatsu, M., Nickander, K. K., Schmelzer, J. D. et al. (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18, 1160-1167
17. 17 Packer, L., Tritschler, H. J. and Wessel, K. (1997) Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Rad. Biol. Med. 22, 359-378
18. 18 Roy, S., Sen, C. K., Tritschler, H. J. and Packer, L. (1997) Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury. Biochem. Pharmacol. 53, 393-399
19. 19 Packer, L. (1995) Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts. Ann. N. Y. Acad. Sci. 738, 257-265
20. 20 Suzuki, Y. J., Tsuchiya, M. and Packer, L. (1991) Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free. Rad. Res. Commun. 15, 255-263
21. 21 Busse, E., Zimmer, G., Schopohl, B. and Kornhuber, B. (1992) Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 42, 829-831
22. 22 Han, D., Tritschler, H. J. and Packer, L. (1995) Alpha-lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem. Biophys. Res. Commun. 207, 258-264
23. 23 Jaffé, W. A., Nachman, R. L., Becker, C. G. and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756
24. 24 Garcia, M. J., McNamara, P. M., Gordon, T. and Kannel, W. B. (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes 23, 105-111
25. 25 Klienman, J. C., Donahue, R. P., Harris, M. I., Finucane, F. F., Madans, J. H. and Brock, D. B. (1988) Mortality among diabetics in a national sample. Am. J. Epidemiol. 128, 389-401
26. 26 Gerrity, R. G. (1991) The role of monocytes in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103, 181-190
27. 27 Bilato, C. and Crow, M. T. (1996) Atherosclerosis and the vascular biology of aging. Aging 8, 221-234
28. 28 De Caterina, R. and Gimbrone, M. A. (1995) Leukocyte - enothelial interactions and the pathogenesis of atheroslerosis. In N-3 Fatty Acids: Prevention and Treatment in Vascular Disease (Kristensen, S. D., Schmidt, E. B., De Caterina, R. and Endres, S., eds.), pp. 9-24, Bi & Gi, London
29. 29 Springer, T. A. (1990) Adhesion receptors of the immune system. Nature (London) 346, 425-434
30. 30 Couffinhal, T., Duplàa, C., Moreau, C., Lamazière, J. D. and Bonnet, J. (1994) Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ. Res. 74, 225-234
31. 31 Beekhuizen, H., Corse van Tilburg, A. J. and Furth, R. (1990) Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J. Immunol. 145, 510-518
32. 32 Lee, T. S., Saltsman, K. A., Ohashi, H. and King, G. L. (1989) Activation of protein kinase C by elevation of glucose: proposal for a mechanism in the development of diabetic vascular complications. Proc. Natl. Acad. Sci. U.S.A. 86, 5141-5145
33. 33 Xia, P., Inoguchi, T., Kern, T. S., Engerman, R. L., Oates, P. J. and King, G. L. (1994) Characterization of the mechanism for the chronic activation of diacylglycerol - protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43, 1122-1129
34. 34 Stitt, A. W., Bucala, R. and Vlassara, H. (1997) Atherogenesis and advanced glycation: promotion, progression, and prevention. Ann. N.Y. Acad. Sci. 811, 115-127; discussion 127-129
35. 35 Kakkar, R., Mantha, S. V., Kalra, J. and Prasad, K. (1996) Time course study of oxidative stress in aorta and heart of diabetic rat. Clin. Sci. 91, 441-448
36. 36 Low, P. A., Nickander, K. K. and Tritschler, H. J. (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (Suppl. 2), S38-S42
37. 37 Gray, R. P., Wickens, D. G., Patterson, D. L. and Yudkin, J. S. (1993) Free-radical activity after reperfusion in diabetic and non-diabetic patients with acute myocardial infarction. Clin. Sci. 85, 549-555
38. 38 Sundaram, R. K., Bhaskar, A., Vijayalingam, S., Viswanathan, M., Mohan, R. and Shanmugasundaram, K. R. (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Sci. 90, 255-260
39. 39 Ceriello, A., Giugliano, D., Quatraro, A. and Lefebvre, P. J. (1991) Antioxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin. Sci. 81, 739-742
40. 40 Vlassara, H., Bucala, R. and Striker, L. (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70, 138-151
41. 41 Baeuerle, P. A. and Henkel, T. (1994) Function and activation of NF-kappaB in the immune system. Annu. Rev. Immunol. 12, 141-179
42. 42 Kachigan, L. M., Collins, T. and Fries, J. W. (1997) N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappaB expression in vivo. Am. J. Pathol. 151, 1225-1229
43. 43 Cominacini, L., Garbin, U., Pasini, A. F. et al. (1997) Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad. Biol. Med. 22, 117-127
44. 44 Vanden Heuvel, J. P., Tyson, F. L. and Bell, D. A. (1993) Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 14, 395-398
45. 45 Benavides, G. R., Hubby, B., Grosse, W. M., McGraw, R. A. and Tarleton, R. L. (1995) Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primers. J. Immunol. Methods 181, 145-156
46. 46 Carantoni, M., Abbasi, F., Chu, L. et al. (1997) Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care 20, 1462-1465
47. 47 Hoogerbrugge, N., Postema, P. T., Verkerk, A., Jongkind, J. F. and Jacobs, M. L. (1996) Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care 19, 1122-1125
48. 48 Haugaard, N. and Haugaard, E. S. (1970) Stimulation of glucose utilization by thioctic acid in rat diaphragm in vitro. Biochim. Biophys. Acta 222, 583-586